搜尋結果
2024年5月22日 · What Is Tenormin? Tenormin (atenolol) is a beta-blocker indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions (heart attacks). What Are Side Effects of Tenormin? Side effects of Tenormin include:
2024年6月3日 · Jardiance (empagliflozin tablet, film coated) is a sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure; to reduce the risk of sustained decline in eGFR, end-stage kidney disease, cardiovascular death, and hospitalization in adult...
2024年5月23日 · Wellbutrin (bupropion) is an antidepressant in the aminoketone class used for the management of major depression and seasonal affective disorder. Wellbutrin is available in generic form. What Are Side Effects of Wellbutrin? Wellbutrin may cause serious side effects including: seizure (convulsions), confusion, unusual changes in mood or behavior,
What Is Triglide? Triglide ( fenofibrate) helps reduce cholesterol and triglycerides ( fatty acids) in the blood and is used to treat high cholesterol and high triglyceride levels. High levels of these types of fat in the blood are associated with an increased risk of atherosclerosis (clogged arteries). What Are Side Effects of Triglide?
2024年5月31日 · Prednisone is a prescription medication used most commonly to treat a variety of common diseases and conditions including acute asthma, rheumatic disorders, more. Learn about side effects, drug interactions, dosages, warnings, and more.
2024年5月31日 · Prednisone is a glucocorticoid indicated to treat or manage many conditions, including: endocrine disorders, rheumatic disorders, collagen diseases, dermatologic diseases, allergies, ophthalmic (eye) diseases, respiratory diseases, hematologic disorders, neoplastic diseases (cancers), edematous states, and. gastrointestinal diseases.
2024年5月17日 · Balversa (erdafitinib) is a kinase inhibitor indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma that has susceptible FGFR3 or FGFR2 genetic alterations, and progressed during or following at least one line of prior platinum-containing chemotherapy including within 12 months of neoadjuvant or ad...
